1  achieved a lower limit of detection of 0.85 ng muL(-1) and a lower limit of quantification of 2.54 ng muL(-1).

2   The assay has a detection limit of 178 amol (89.6 fg) and a lower limit of quantification of 700 amol (350 fg) of deriv

3 9%, interday and intraday imprecision of 7.5% or lower, and a lower limit of quantification of 0.5 microg/L, equivalent t

4                         CSF and plasma HIV-1 RNA assays had a lower limit of quantification of 2.5 copies/mL.

5                                        The final method has a lower limit of quantification of 20 ng/mL (ca. 350 pM) and

6 onin, after solid-phase extraction from plasma, resulted in a lower limit of quantification of 10 pg/mL, while introducti

7 odology for quantitative gelatin species determination with a lower limit of quantification of 0.05%.

8 ethod shows linearity over a range of 0.65-821 mBq/mL, with a lower limit of quantification of 0.65 mBq/mL (corresponding

9 nts of the FDA and EMA guidelines for assay validation with a lower limit of quantification of 2.5 ng/mL for the ERAs, 5